Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Prenuvo mobile whole-body MRI clinic

Startup Prenuvo to park ‘luxury’ whole-body MRI truck on Canadian border amid regulatory challenges

Despite amassing a wait list of 10,000 individuals, the company has confronted “significant barriers due to restrictions on private imaging services in Ontario.” 

mammography mammogram breast imaging

FDA issues guidance to help imaging providers comply with new mammography requirements

Beginning September 10, breast imaging facilities will be required to notify patients about the density of their breasts, among other regulatory changes. 

Siemens Healthineers

Siemens Healthineers to acquire Novartis imaging unit for over $223M

The Swiss pharmaceutical firm operates Europe’s second largest network of cyclotrons, used to manufacture radioactive compounds needed for PET scans.  

CMS could increase CCTA payments—the American College of Cardiology wants to help

CMS wants feedback after proposing a significant update to CCTA reimbursement payments. The American College of Cardiology, a longtime champion for improved cardiac CT payments, is now helping its members make their voices heard.

Thumbnail

'Game changer' prostate imaging agent granted FDA's Fast Track designation

The PET agent was developed for men with PSMA-positive lesions who have suspected metastasis and are candidates for initial definitive therapy.

Thumbnail

Brain enlargement may be linked to symptom severity in kids with autism spectrum disorder

Social and communication symptoms appear to be more severe in children who display brain overgrowth on MRI scans.

CT findings linked with pancreatic cancer

CT findings linked to heightened risk of pancreatic cancer recurrence

In 2023, the Society of Abdominal Radiology released its consensus statement regarding follow-up imaging of patients who have had their cancer surgically resected.

AISAP, an Israeli healthcare technology company focused on using artificial intelligence (AI) to enhance medical imaging results, has gained U.S. Food and Drug Administration (FDA) clearance for its new point-of-care ultrasound (POCUS) software platform, AISAP Cardio.

FDA clears AI-powered POCUS platform for structural heart disease, heart failure

The cloud-based platform was designed to help even inexperienced users scan and diagnose a majority of common heart issues within minutes without leaving the patient’s side.